Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism
Conditions
Interventions
None listed
Sponsors
Sunil Gunderao Solanke
Eligibility
Inclusion criteria
Inclusion criteria: i) Patients having Serum TSH level between 4 to 20 mIU/L. ii) Patients having Serum T3 and Serum T4 level within normal range. iii) Patients who are willing to participate in study.
Exclusion criteria
Exclusion criteria: i) Patients with MI, Stroke, Cardio Vascular surgery or major operations within 6 months prior to screening visit. ii) Patients having TSH level more than 20 mIU/L or having symptoms of Myxoedema. iii) Patient with previous radiation treatment of the thyroid gland. iv) Women who are pregnant or have a plan to become pregnant in the near future. v) Patient suffering from uncontrolled DM or uncontrolled Hypertension.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i)To decrease the serum TSH level in Subclinical Hypothyroidism after oral administration of Takrarishta for 60 days.Timepoint: 0 day ( 1st visit), 30th day ( 1st follow up) 60th day ( last follow up) | — |
Secondary
| Measure | Time frame |
|---|---|
| i)To decrease body weight and Body Mass Index in Subclinical Hypothyroidism after oral administration of Takrarishta for 60 days. ii) To decrease clinical features (if any) in Subclinical Hypothyroidism after oral administration of Takrarishta for 60 days.Timepoint: 0 day ( 1st visit), 30th day ( 1st follow up) 60th day ( last follow up) | — |
Countries
India
Contacts
Public ContactBhagwat T Shinde
PMTs Ayurved College and Eknath Ayurved Rugnalaya, Shevgaon
Outcome results
None listed